Product Information

CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by BluePoint Laboratories, priced at $0.0241 per ML under NDC 68001052194. Its NADAC has been published 168 times since Jun 7, 2023.

FDA first approved this application on Apr 17, 2018.

The Low Outlier badge above means this manufacturer's average price in the Ibuprofen market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CHILDREN IBUPROFEN 100 MG/5 ML

Ibuprofen
$0.0241per ML
Low Outlier
OTC

Strength

100 mg/5mL

NDC

68001052194

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA209179

FDA Approved

4/17/2018

On Market Since

9/12/2022

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 168 times since Jun 7, 2023, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0241 per ML
All-time high$0.0253 (Jul 10, 2024)
All-time low$0.0231 (Oct 23, 2024)
52-week high$0.0250
52-week low$0.0236
Median price$0.0240
Average price$0.0241
Largest weekly change+4.5% (Nov 20, 2024)
Weeks tracked168
Tracking sinceJun 7, 2023

Price History

1W

-1.3%

1M

-3.7%

3M

-2.7%

6M

+0.2%

1Y

+1.5%

3Y

+1.1%

5Y

N/A

All

-1.0%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?

The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by BluePoint Laboratories, is $0.0241 per ML (NDC 68001052194), effective Aug 19, 2026.

How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?

Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has held within roughly two percent of its current level. It has been tracked across 168 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?

Since Jun 7, 2023, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0231 (Oct 23, 2024) to a high of $0.0253 (Jul 10, 2024), with a median of $0.0240 per ML.

Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0239 per ML — about 1% below CHILDREN IBUPROFEN 100 MG/5 ML.

Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?

CHILDREN IBUPROFEN 100 MG/5 ML (NDC 68001052194) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.